Litcius/Paper detail

Pharmacokinetics of the oral multikinase inhibitor regorafenib and its association with real‐world treatment outcomes

Masahide Fukudo, Keiko Asai, Chikayoshi Tani, Masashi Miyamoto, Katsuyoshi Ando, Nobuhiro Ueno

2021Investigational New Drugs14 citationsDOI

Topics & Concepts

RegorafenibMedicinePharmacokineticsInternal medicineHepatocellular carcinomaDosingSorafenibGiSTGastroenterologyColorectal cancerOncologyToxicityPharmacologyUrologyCancerStromal cellColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology ResearchHepatocellular Carcinoma Treatment and Prognosis
Pharmacokinetics of the oral multikinase inhibitor regorafenib and its association with real‐world treatment outcomes | Litcius